These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9920156)

  • 1. Troglitazone and vascular reactivity: role of glucose and calcium.
    Ali SS; Igwe RC; Walsh MF; Sowers JR
    Metabolism; 1999 Jan; 48(1):125-30. PubMed ID: 9920156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic actions of insulin and troglitazone on contractility in endothelium-denuded rat aortic rings.
    Goud C; Pitt B; Webb RC; Richey JM
    Am J Physiol; 1998 Nov; 275(5):E882-7. PubMed ID: 9815009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats.
    Naderali EK; Pickavance LC; Wilding JP; Doyle PJ; Williams G
    Eur J Pharmacol; 2001 Mar; 416(1-2):133-9. PubMed ID: 11282122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.
    Walker AB; Naderali EK; Chattington PD; Buckingham RE; Williams G
    Diabetes; 1998 May; 47(5):810-4. PubMed ID: 9588454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production.
    Song J; Walsh MF; Igwe R; Ram JL; Barazi M; Dominguez LJ; Sowers JR
    Diabetes; 1997 Apr; 46(4):659-64. PubMed ID: 9075808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes.
    Ren J; Dominguez LJ; Sowers JR; Davidoff AJ
    Diabetes; 1996 Dec; 45(12):1822-5. PubMed ID: 8922371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
    Fürnsinn C; Neschen S; Noe C; Bisschop M; Roden M; Vogl C; Schneider B; Waldhäusl W
    Br J Pharmacol; 1997 Dec; 122(7):1367-74. PubMed ID: 9421284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery.
    Kawasaki J; Hirano K; Nishimura J; Fujishima M; Kanaide H
    Circulation; 1998 Dec; 98(22):2446-52. PubMed ID: 9832491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation by 4-aminopyridine of delayed vasorelaxation by troglitazone.
    Peuler JD; Warfield RK; Phelps LE
    Metabolism; 2004 Feb; 53(2):147-52. PubMed ID: 14767864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of troglitazone and nitric oxide on glucose uptake in L929 fibroblast cells.
    Van Dyke DA; Walters L; Frieswyk D; Kokmeyer D; Louters LL
    Life Sci; 2003 Apr; 72(21):2321-7. PubMed ID: 12639698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone inhibits voltage-dependent calcium currents in guinea pig cardiac myocytes.
    Nakajima T; Iwasawa K; Oonuma H; Imuta H; Hazama H; Asano M; Morita T; Nakamura F; Suzuki J; Suzuki S; Kawakami Y; Omata M; Okuda Y
    Circulation; 1999 Jun; 99(22):2942-50. PubMed ID: 10359740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
    Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
    Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes.
    Knock GA; Mishra SK; Aaronson PI
    Eur J Pharmacol; 1999 Feb; 368(1):103-9. PubMed ID: 10096775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone has no effect on K(ATP) channel opener induced-relaxations in rat aorta and in human saphenous veins from patients with type 2 diabetes.
    Yöntem O; Sahilli M; Karasu C; Ozçelikay AT; Altan VM; Ari N
    Life Sci; 2000 Dec; 68(5):557-68. PubMed ID: 11197753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells.
    Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
    Circ Res; 1997 Dec; 81(6):953-62. PubMed ID: 9400375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of vascular tone by introduction of troglitazone to the canine coronary artery.
    Osanai H; Toki Y; Nakashima Y; Okumura K; Ito T; Hayakawa T
    Arzneimittelforschung; 1999 Jan; 49(1):26-9. PubMed ID: 10028375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.